Welch Allyn Spot Vision Screener - ROQUE Eye Clinic | Eye.com.ph

Welch Allyn Spot Vision Screener

PRICE

Original price was: ₱ 787.00.Current price is: ₱ 560.00.

OVERVIEW, TERMS & CONTACT INFO

OVERVIEW

Welch Allyn Spot Vision Screener is a quick, non-contact vision screening test that checks for refractive error and eye alignment risk factors. It works well for children and adults and delivers results in seconds. The screening helps identify who needs a complete eye examination.

TERMS AND CONDITIONS, INCLUSIONS, AND EXCLUSIONS

1. Service includes automated non-contact vision risk screening only.
2. Results are screening indicators and do not replace a full eye examination.
3. Professional clinical correlation by the ophthalmologist is required.
4. Fees may vary when combined with other diagnostic services.
5. Accuracy depends on patient fixation and cooperation.
6. Screening may be repeated if image quality is insufficient.
7. Definitive diagnosis and prescriptions are not included.

CONTACT INFORMATION

Dr. Manolette Roque | Dr. Barbara Roque
St. Luke’s Medical Center – Global City
2nd Floor, Units 217-218, Roque Eye Clinic, Medical Arts Building
Rizal Drive cor. 5th Ave, Taguig City 1634, Philippines
+63-917-844-2020
+63-998-998-2020
+63-2-8828-2020
+63-2-8789-7700 ext. 7217
+63-2-8789-7700 ext. 7218

Dr. Manolette Roque | Dr. Barbara Roque
Asian Hospital and Medical Center
5th Floor, Unit 509, Roque Eye Clinic, Medical Office Building
2205 Civic Drive, Alabang, Muntinlupa City 1781, Philippines
+63-917-795-2020
+63-998-997-2020
+63-2-8771-9253
+63-2-8771-9000 ext. 7509

DETAILS

WELCH ALLYN SPOT VISION SCREENER

Welch Allyn Spot Vision Screener is a fast, handheld, non-contact eye screening service that checks for common vision problems and risk factors in both children and adults. It uses automated infrared technology to estimate refractive error and eye alignment within seconds. As a result, it helps detect possible vision issues early and supports timely referral and treatment.

WHAT THIS SERVICE DOES

This screening measures key visual risk indicators without touching the eye. It estimates nearsightedness, farsightedness, astigmatism, and unequal refractive power between the eyes. In addition, it evaluates pupil size and eye alignment. Therefore, it helps identify patients who may need a full eye examination.

The device captures data from about one meter away. Because it works quickly, it is especially useful for young children, seniors, and patients with limited cooperation.

WHO BENEFITS FROM THIS SCREENING

This service supports early detection across many age groups. For example, it is widely used in pediatric and primary eye care settings.

1. Infants and children needing early vision risk screening
2. School-age children with suspected refractive error
3. Adults needing rapid baseline screening
4. Patients with communication or developmental limits
5. Community and preventive vision programs

HOW THE SCREENING IS PERFORMED

The screening is simple and quick. First, the patient looks toward the handheld device. Next, the screener captures both eyes at the same time from a short distance. Then, automated analysis provides a pass or refer result based on preset criteria. Consequently, the process usually finishes within seconds.

No eye drops, air puff, or contact instruments are required. Moreover, dilation is not needed for routine screening.

PATIENT COMFORT AND SAFETY

The Welch Allyn Spot Vision Screener uses safe infrared light and non-contact capture. Because nothing touches the eye, discomfort is minimal. Most patients complete the test easily. In addition, normal activities can resume immediately after screening.

WHY EARLY VISION RISK DETECTION MATTERS

Early detection of refractive error and alignment problems supports better visual development and daily function. For instance, untreated childhood vision issues may affect learning and behavior. Likewise, uncorrected adult refractive errors reduce work and driving safety. Therefore, rapid screening helps guide timely comprehensive eye evaluation.